Surmodics Releases Pounce XL Thrombectomy System

Surmodics has released the Pounce XL thrombectomy system, the latest in its suite of Pounce systems for rapid removal of acute or chronic clot from peripheral arteries.

Pounce XL is meant for removal of thrombi and emboli from peripheral arteries ranging from 5.5-10 mm in diameter, the sizes typical of iliac and femoral arteries. It complements the Pounce and Pounce LP (low-profile) thrombectomy systems, which are meant for use in 3.5-6 mm and 2-4 mm arteries, respectively.

Pounce XL was granted U.S. Food and Drug Administration (FDA) 510(k) clearance in October 2024.

The fully mechanical Pounce platform uses dual-basket tech to remove clots without capital equipment. It’s associated with low risk of distal embolization and doesn’t require thrombolytics. It uses no aspiration for clot removal to minimize blood loss and is atraumatic to vessel walls, with low risk of flow-limiting dissection.

Pounce XL has been in limited market release since January 2025. Dr. Anna Marjan, a vascular surgeon at Allina Health Mercy Hospital in Coon Rapids, Minn., was among the physicians who used Pounce XL during the product’s limited release.

“Removing organized clot from large peripheral arteries without a surgical cutdown can be very challenging,” Dr. Marjan said. “In our first use of the Pounce XL Thrombectomy System we were able to extract a large amount of acute and subacute clot from the infrarenal aorta and common iliac arteries in a severely ischemic patient with just 3 passes of the device. Avoiding surgical cutdown reduces the need for general anesthesia and reduces risk of surgical-site infection, which benefits patients. The Pounce Thrombectomy Platform is my first-line, go-to solution for endovascular thrombectomy in peripheral arteries.”

“The addition of the Pounce XL Thrombectomy System fulfills our vision of providing a simple, effective platform for removing peripheral arterial blood clots throughout the leg,” said Gary Maharaj, president and CEO of Surmodics. “When minutes matter, physicians appreciate the availability of a readily deployable solution with a track record of dependable and safe results. We’re proud of the growing clinical adoption of this product and the benefits it is bringing to limb ischemia patients in need of urgent care.”